These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 203419)

  • 21. Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3.
    Peacock M; Aaron JE; Walker GS; Davison AM
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():73s-81s. PubMed ID: 606428
    [No Abstract]   [Full Text] [Related]  

  • 22. Nutritional and metabolic rickets.
    Teotia M; Teotia SP
    Indian J Pediatr; 1997; 64(2):153-7. PubMed ID: 10771831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
    Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
    Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).
    al-Aqeel A; Ozand P; Sobki S; Sewairi W; Marx S
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):229-37. PubMed ID: 8396512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D therapy: problems and prospects.
    Drug Ther Bull; 1975 Apr; 13(8):29-31. PubMed ID: 165927
    [No Abstract]   [Full Text] [Related]  

  • 26. [Administration of phosphates and 1 alpha-hydroxyvitamin D3 during the postoperative immobilization of children with familial hypophosphatemic rickets].
    Pronicka E; Wieczorek E; Kulczycka H; Rowińska E; Tylman D; Pomierna I; Fijałkowski S
    Pol Tyg Lek; 1985 Sep; 40(35):992-6. PubMed ID: 4070045
    [No Abstract]   [Full Text] [Related]  

  • 27. Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis.
    Ellis HA; Pierides AM; Feest TG; Ward MK; Kerr DN
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():31s-38s. PubMed ID: 606422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of hypophosphataemic vitamin D-resistant rickets treated with initial massive doses of 1 alpha-hydroxy-vitamin D3 alone.
    Muraki K; Nishi Y; Tsuda K; Yoshimitsu K; Usui T
    Acta Paediatr Scand; 1983 Sep; 72(5):763-8. PubMed ID: 6314737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.
    Balsan S; Garabedian M
    J Clin Invest; 1972 Apr; 51(4):749-59. PubMed ID: 4335443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autosomal hypophosphataemic bone disease responds to 1,25-(OH)2D3.
    Scriver CR; Reade T; Halal F; Costa T; Cole DE
    Arch Dis Child; 1981 Mar; 56(3):203-7. PubMed ID: 7212758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing the response to 1alpha-hydroxyvitamin D3 in patients with renal bone disease.
    Kanis JA; Russell RG; Naik RB; Earnshaw M; Smith R; Heynen G; Woods CG
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():51s-57s. PubMed ID: 606425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum 25-hydroxyvitamin D in infantile rickets.
    Arnaud SB; Stickler GB; Haworth JC
    Pediatrics; 1976 Feb; 57(2):221-5. PubMed ID: 175345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutritional rickets & osteomalacia: A practical approach to management.
    Uday S; Högler W
    Indian J Med Res; 2020 Oct; 152(4):356-367. PubMed ID: 33380700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia.
    Christiansen C; Rodbro P; Munck O
    Br Med J; 1975 May; 2(5967):363-5. PubMed ID: 165857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia.
    Cohanim M; DeLuca HF; Yendt ER
    Johns Hopkins Med J; 1972 Aug; 131(2):118-32. PubMed ID: 4340527
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid.
    Hirschman GH; DeLuca HF; Chan JC
    Pediatrics; 1978 Mar; 61(3):451-7. PubMed ID: 25411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vitamin D-resistant rickets type II: apropos of 2 cases].
    Simonin G; Chabrol B; Moulene E; Bollini G; Strouc S; Mattei JF; Giraud F
    Pediatrie; 1992; 47(12):817-20. PubMed ID: 1338926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia.
    Peacock M; Aaron JE; Heyburn PJ; Nordin BE
    Adv Exp Med Biol; 1977; 81():431-40. PubMed ID: 899935
    [No Abstract]   [Full Text] [Related]  

  • 39. [Idiopathic hypophosphataemic osteomalacia (author's transl)].
    Offermann G; von Herrath D; Delling G
    Dtsch Med Wochenschr; 1976 Nov; 101(46):1684-9. PubMed ID: 186246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D metabolism in biliary atresia: intestinal absorptions of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3.
    Kimura S; Seino Y; Harada T; Nose O; Yamaoka K; Shimizu K; Tanaka H; Yabuuchi H; Fukui Y; Kamata S
    J Pediatr Gastroenterol Nutr; 1988; 7(3):341-6. PubMed ID: 3260278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.